Uri Yablonka

Chief Operating Officer, BRAINSTORM CELL THERAPEUTICS INC.

Companies

BRAINSTORM CELL THERAPEUTICS INC.EVP & Chief Business Officer Jul 17, 2017 to now¹
BRAINSTORM CELL THERAPEUTICS INC.Board member Jun 9, 2014 to now²
BRAINSTORM CELL THERAPEUTICS INC.Chief operating officer Jun 9, 2014 to Jun 23, 2016²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

BRAINSTORM CELL THERAPEUTICS INC. BCLI218,464 shares³$169.3K at $0.78Feb 26, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 26, 2026Granted 150,000 shares of BRAINSTORM CELL THERAPEUTICS INC.³
Jan 1, 2025Granted 20,000 shares of BRAINSTORM CELL THERAPEUTICS INC.⁴
Jan 1, 2025Granted 40,000 shares of BRAINSTORM CELL THERAPEUTICS INC.⁴
Mar 11, 2024Granted 109,426 shares of BRAINSTORM CELL THERAPEUTICS INC.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBRAINSTORM CELL THERAPEUTICS INC., EVP & Chief Business Officer
2
SEC EDGARBRAINSTORM CELL THERAPEUTICS INC., Board member
3
SEC EDGARBRAINSTORM CELL THERAPEUTICS INC. shares after the filing of Feb 26, 2026
4
SEC EDGARForm 4 filed Jan 3, 2025
5
SEC EDGARForm 4 filed Mar 13, 2024